Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-03-14 15:50:52 |
Versijas komentārs | |
Teksts |
Olainfarm holds Investor Conference Webinar about financial results
of 2015
AS „Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its investor
conference webinar scheduled on March 14, 2016 at 16:00
(EET).
To join the webinar please follow the instructions
below.
Webinar is hosted by the Member of the Management Board
Salvis Lapiņš. The presentation is held in
English.
Salvis Lapiņš informs about AS “Olainfarm” latest activities and
analyzes the financial results of the fourth quarter 2015 and
non-audited financial results of 12 months 2015.
After the presentation investors are welcome to ask
questions.
During the webinar the enclosed presentation is being
presented.
What is webinar?
How to join the webinar?
To join the webinar, we invite you to register via
ej.uz/OLF_YE2015.
You will be provided with the webinar link and instructions to join
webinar successfully. When joining the webinar for the first time,
you will be asked to download the system application on your
computer which will take only few seconds.
For more information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in
Latvia with more than 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and
Australia.
Information prepared by: |
Pielikumi |